The Bermekimab Biosimilar Anti-IL1A Antibody is a cutting-edge product designed for research involving IL1A, a key player in the immune response and inflammation. This biosimilar antibody, modeled after the original Bermekimab antibody, offers researchers a reliable and effective tool for studying IL1A pathways and functions.Raised in specialized cell lines, this antibody exhibits high specificity and binding affinity to IL1A, ensuring accurate and consistent results in various experimental settings. It is suitable for a range of applications, including ELISA, immunohistochemistry, and flow cytometry, providing researchers with versatile options for their studies.IL1A is a potent pro-inflammatory cytokine implicated in a wide range of diseases, including chronic inflammatory conditions, autoimmune disorders, and cancer.
By targeting IL1A with the Bermekimab Biosimilar Anti-IL1A Antibody, researchers can gain valuable insights into the role of this cytokine in disease pathogenesis and potential therapeutic interventions.Overall, the Bermekimab Biosimilar Anti-IL1A Antibody offers researchers a powerful tool for advancing their understanding of IL1A biology and its implications for human health. Its high quality and reliability make it a valuable addition to any research laboratory focused on immune response and inflammatory diseases.
Product Name:
Bermekimab (Anti-IL1A) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0086
Target:
IL1A
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
MABp1
Description:
Anti-IL1A(bermekimab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
